- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02153047
Multicentric Randomized Clinical Trial to Evaluate the Long-term Effectiveness of a Motivational Intervention Against Smoking, Based on the Information Obtained From Spirometry in Primary Care. (RESET-ESPITAP2)
There is controversy about the effectiveness of interventions based on spirometry for smoking cessation.
The investigators want to evaluate the effectiveness of motivational intervention performed by a doctor to obtain abstinence compared with normal practice in primary care.
This study, is the second half of what was began with ESPITAP study
Study Overview
Detailed Description
Design: Multicentric randomized clinical trial with two groups. Setting: 20 primary care centers inTarragona. Subjects: 1100 active smokers (consumption>10 packs/year) aged 35-70, seeking medical advice for any reason, with no exclusion criteria, will be randomized to receive the intervention or not.
Intervention: A 20-minutes visit with details of the spirometry data (values of respiratory capacity and volumes referring on the theoretical). The lung age index will be reported compared to chronological age to illustrate lung damage suffered as a result of tobacco consumption.
Measurements: Basal Spirometry. Structured questionnaire interviewed in the center at 0 and 12 months and telephone interview at 3 and 6 months. At 12 months, patients who stopped smoking will perform a CO test and if the CO exhaled will be <10ppm abstinence will be verified by determination of urinary cotinine.
Primary endpoint: Cessation of tobacco consumption at 12 months. Analysis: Data will be analyzed in the "intent to treat", the unit of analysis will be the smoker.
Expected Results: smoking cessation in the intervention group will exceed at least 5% the achieved by normal practice in primary care.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Barcelona, Spain, 08007
- Jordi Gol i Gurina Foundation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Active smokers (consumption>10 packs/year)
Exclusion Criteria:
- Active respiratory disease
- Practice of an espirometry on 12 months before
- Suffering of any chronic or terminal disorder
- Counterindication to undertake spirometry or that may hinder the performance of the spirometry test
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Spirometry
Will be given a brief but structured smoking cessation advice (according to the standards of the Tobacco Study Group of the Catalan Society of Family Medicine) together with a detailed and structured 20-minutes visit with details of the spirometry data (values of respiratory capacity and volumes referring on the theoretical)
|
Will be given a brief but structured smoking cessation advice (according to the standards of the Tobacco Study Group of the Catalan Society of Family Medicine) together with a detailed and structured 20-minutes visit with details of the spirometry data (values of respiratory capacity and volumes referring on the theoretical)
|
|
No Intervention: Brief smoking cessation advice
Will be given a brief but structured smoking cessation advice (according to the standards of the Tobacco Study Group of the Catalan Society of Family Medicine).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cessation of tobacco consumption at 12 months.
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Smoking reduction: self reported reduction
Time Frame: 12 Months
|
Smoking reduction by self reported reduction
|
12 Months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Antoni Santigosa-Ayala, MD, Catalan Institute of Health
- Study Director: Francisco Martín-Luján, PhD, Catalan Institute of Health
- Study Chair: Rosa Sola-Alberich, MD, Catalan Institute of Health
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PI11/01962
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
Clinical Trials on Spirometry
-
Taipei Medical University Shuang Ho HospitalNot yet recruitingSleep Apnea, Obstructive | Bariatric Surgery Candidate
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Ministry of Health, Brazil; Conselho... and other collaboratorsUnknown
-
Riphah International UniversityCompletedHiatal Hernia | Cholecystitis | Choledocholithiasis | Splenomegaly | Diaphragmatic Hernia | Perforated Duodenal Ulcer | Malignant Pancreatic Neoplasm | Benign Pancreas Tumor | Splenic InfarctionPakistan
-
Centre Hospitalier Metropole SavoieCompletedRespiratory FunctionFrance
-
Cliniques universitaires Saint-Luc- Université...CompletedSpirometry | Respiratory Function TestsBolivia
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Ministry of Health, Brazil; Conselho...UnknownChronic Obstructive Pulmonary DiseaseBrazil
-
Gelb, Arthur F., M.D.The Hospital for Sick Children; Stony Brook University; Miller Children's & Women...RecruitingCystic Fibrosis in ChildrenUnited States
-
University Hospital, BordeauxInstitut National de la Santé Et de la Recherche Médicale, FranceTerminatedChronic Obstructive Pulmonary DiseaseFrance
-
University Hospital Inselspital, BerneCompletedLung Diseases | Surgery | Lung Function DecreasedSwitzerland
-
Col·legi de Farmacèutics de la Província de BarcelonaHospital Clinic of Barcelona; Fundació Institut de Recerca de l'Hospital de... and other collaboratorsUnknownChronic Obstructive Pulmonary Disease Case Finding in Community-pharmacies by Spirometry (FARMAEPOC)Chronic Obstructive Pulmonary DiseaseSpain